Paritosh Nayak is a seasoned investment professional currently serving as Vice President of Investments at InvAscent. With experience as an investor and board observer at Maiva Pharma Private Limited, Fleming Laboratories, Symbiotec Pharmalab Pvt. Ltd., and SANDOR MEDICAIDS PVT. LTD., Paritosh demonstrates a strong expertise in the pharmaceutical sector. Educationally, Paritosh holds a Master of Business Administration in Finance and Operations from the Indian School of Business (2019-2020) and a Master of Pharmacy in Pharmaceutics from Jadavpur University (2006-2008).
This person is not in the org chart
This person is not in any teams
Maiva Pharma Private Limited (FDA Approved Sterile Injectables)
Maiva Pharma Private Limited, formerly known as Global Pharmatech, started operations in 1996, as a manufacturer of high quality liquid sterile formulations in small volume glass vials and ampoules, and large volume glass bottles. With a strong commitment to Quality and Compliance, Maiva has built a reputation in the industry for quality and reliability. The facility is capable of manufacturing both aseptically filled and terminally sterilized products. Maiva has USFDA EU-GMP, Health Canada, PIC/S, With two decades of experience in Sterile Manufacturing, Maiva have capabilities to perform end to end integrated pharmaceutical development and manufacturing ranging from literature search, formulation development, analytical methods development and validation, stability studies, global regulatory management, cGMP manufacturing till supply of commercial sterile injectables products. Maiva's facility spreads across a 5-acre plot, in Hosur, Tamil Nadu (outskirts of Bangalore). The manufacturing unit consists of an integrated ampoule line and an integrated glass vial line. In the last few years, Maiva has emerged as a prominent injectables manufacturer by leveraging India cost advantage and scientific talents and by following stringent quality systems. Offers:Injectables